Related Experiment Video
Updated: May 30, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Quality of reporting of neonatal and infant trials in high-impact journals
Sara B DeMauro1, Annie Giaccone, Haresh Kirpalani
1Department of Pediatrics, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. demauro@email.chop.edu
Insights
Reporting quality for infant and neonatal randomized controlled trials (RCTs) is inconsistent, hindering validity assessment. Adhering to Consolidated Standards of Reporting Trials (CONSORT) guidelines can improve the quality of these crucial pediatric studies.
Area of Science:
- Pediatric Research
- Clinical Trial Methodology
- Neonatal Medicine
Background:
- Reporting quality of randomized controlled trials (RCTs) is crucial for assessing study validity.
- Infant and neonatal populations require specific considerations in clinical trial design and reporting.
- High-impact journals often publish significant pediatric research, making their reporting standards critical.
Purpose of the Study:
- To systematically review the reporting quality of infant and neonatal RCTs published in high-impact journals.
- To identify characteristics of RCTs that correlate with higher quality of reporting.
- To provide recommendations for improving the reporting standards of pediatric RCTs.
Main Methods:
- Systematic review of RCTs involving infants (<12 months) published between 2005-2009 in six leading pediatric and general medical journals.
- Evaluation of 179 eligible RCTs using 11 quality criteria from the Consolidated Standards of Reporting Trials (CONSORT) guidelines.
- Nonparametric statistical methods were used to analyze the relationship between reporting quality and study characteristics.
Main Results:
- Reporting quality varied significantly across the 179 reviewed RCTs.
- While 99% reported participant numbers, only 50% included a flow diagram.
- Higher reporting quality was associated with larger participant numbers, multi-center studies, and publication in general medical journals (P < .0001).
Conclusions:
- The quality of reporting for infant and neonatal RCTs is inconsistent, particularly in pediatric-focused journals.
- Inconsistent reporting compromises the accurate assessment of the validity of many RCT findings.
- Adherence to CONSORT guidelines is recommended to enhance the reporting quality of pediatric RCTs.
Objectives:
To perform a systematic review of the quality of reporting for randomized controlled trials (RCTs) with infants and neonates that were published in high-impact journals and to identify RCT characteristics associated with quality of reporting.
Methods:
RCTs that enrolled infants younger than 12 months and were published in 2005-2009 in 6 pediatric or general medical journals were reviewed. Eligible RCTs were evaluated for the presence of 11 quality criteria selected from the Consolidated Standards of Reporting Trials guidelines. The relationships between quality of reporting and key study characteristics were tested with nonparametric statistics.
Results:
Two reviewers had very good agreement regarding the eligibility of studies (κ = 0.85) and the presence of quality criteria (κ = 0.82). Among 179 eligible RCTs, reporting of the individual quality criteria varied widely. Only 50% included a flow diagram, but 99% reported the number of study participants. Higher quality of reporting was associated with greater numbers of study participants, publication in a general medical journal, and greater numbers of centers (P < .0001 for each comparison). Geographic region and positive study outcomes were not associated with reporting quality.
Conclusions:
The quality of reporting of infant and neonatal RCTs is inconsistent, particularly in pediatric journals. Therefore, readers cannot assess accurately the validity of many RCT results. Strict adherence to the Consolidated Standards of Reporting Trials guidelines should lead to improved reporting.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Bias in Epidemiological Studies

